Facilitating Decentralised Clinical Trials in the EU

  • Home
  • Newsroom
  • Facilitating Decentralised Clinical Trials in the EU
Facilitating Decentralised Clinical Trials in the EU - Axcellant

Facilitating Decentralised Clinical Trials in the EU

  1. gru 19, 2022

The European Commission (EC), the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have published recommendations that aim to facilitate the conduct of decentralised clinical trials (DCTs) while safeguarding the rights and well-being of participants as well as the robustness and reliability of the data collected.

Clinical Trials in the European Union (ACT EU).

https://www.ema.europa.eu/en/news/facilitating-decentralised-clinical-trials-eu

Read more

Key Considerations for Initiating a Clinical Trial: A Comprehensive Guide

Initiating a clinical trial is akin to embarking on a voyage of discovery in the realm of medicine. This journey,…

Completion of a significant clinical study

Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study. This study was…

Unveiling Real-World Evidence in Clinical Trials

In the ever-evolving realm of pharmaceuticals and healthcare, a remarkable transformation is afoot - one that's reshaping the way we…